Company intelligence / Profile preview
Infinant Health
- Ownership
- Private
- Employees
- ~75
- Development stage
- Commercial
Overview
The company’s lead product Evivo®—a daily probiotic powder containing activated B. infantis EVC001—has demonstrated efficacy in restoring healthy gut bacteria in infants fed breast milk. Clinical studies show it reduces pathogenic bacteria by up to 80% and significantly lowers intestinal inflammation associated with a range of short-term and long-term health risks such as NEC and allergies. The company continues to expand its clinical research into new pediatric indications including atopic dermatitis prevention.
- Therapeutic areas
- GastroenterologyDermatology
- Modalities
- Probiotics/microbial therapeutics (notably B. infantis EVC001)Medical foods/dietary supplementsDigital health medical devices (in development)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Infinant Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Infinant Health.